<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="discussion" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Reprod. Health</journal-id>
<journal-title>Frontiers in Reproductive Health</journal-title><abbrev-journal-title abbrev-type="pubmed">Front. Reprod. Health</abbrev-journal-title>
<issn pub-type="epub">2673-3153</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/frph.2022.1096175</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reproductive Health</subject>
<subj-group>
<subject>Opinion</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Advantages of individualizing the placenta accreta spectrum management</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Palacios-Jaraquemada</surname><given-names>Jos&#x00E9; Miguel</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Nieto-Calvache</surname><given-names>&#x00C1;lbaro Jose</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1592464/overview" /></contrib>
<contrib contrib-type="author"><name><surname>Aryananda</surname><given-names>Rozy Aditya</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Basanta</surname><given-names>Nicol&#x00E1;s</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Department of Gynaecology, Otamendi Hospital</institution>, <addr-line>Buenos Aires</addr-line>, <country>Argentina</country></aff>
<aff id="aff2"><label><sup>2</sup></label><addr-line>Cl&#x00ED;nica de Espectro de Acretismo Placentario</addr-line>, <institution>Fundaci&#x00F3;n Valle del Lili</institution>, <addr-line>Cali</addr-line>, <country>Colombia</country></aff>
<aff id="aff3"><label><sup>3</sup></label>Latin American Group for the Study of Placenta Accreta Spectrum, Cali, Columbia</aff>
<aff id="aff4"><label><sup>4</sup></label><addr-line>Dr. Soetomo Academic General Hospital</addr-line>, <institution>Universitas Airlangga</institution>, <addr-line>Surabaya</addr-line>, <country>Indonesia</country></aff>
<aff id="aff5"><label><sup>5</sup></label><institution>Department of Obstetrics an Gynaecology, Hospital General de Agudos Juan A Fern&#x00E1;ndez</institution>, <addr-line>Buenos Aires</addr-line>, <country>Argentina</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Gabriele Saccone, Federico II University Hospital, Italy</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Michal Silber, University of Pennsylvania, United States</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> &#x00C1;lbaro Jose Nieto-Calvache <email>albaro.nieto@fvl.org.co</email></corresp>
<fn fn-type="other" id="fn001"><p><bold>Specialty Section:</bold> This article was submitted to Gynecology, a section of the journal Frontiers in Reproductive Health</p></fn>
<fn fn-type="other" id="fn002"><p>Abbreviations UA, uterine artery; SVA, superior vesical artery; NFV, Newly formed vessels; ObtA, obturator artery; IIA, internal iliac artery; UretV, Ureteral vessels; CA, cervical artery; VA, vaginal arteries; IVA, inferior vesical artery; OA, ovarian artery; IMA, inferior mesenteric artery; ARA, anterior rectal artery; IRAA, infrarenal aortic artery; CIA, common iliac artery.</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>06</day><month>01</month><year>2023</year></pub-date>
<pub-date pub-type="collection"><year>2022</year></pub-date>
<volume>4</volume><elocation-id>1096175</elocation-id>
<history>
<date date-type="received"><day>11</day><month>11</month><year>2022</year></date>
<date date-type="accepted"><day>28</day><month>11</month><year>2022</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2023 Palacios-Jaraquemada, Nieto-Calvache, Aryananda and Basanta.</copyright-statement>
<copyright-year>2023</copyright-year><copyright-holder>Palacios-Jaraquemada, Nieto-Calvache, Aryananda and Basanta</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<kwd-group>
<kwd>placenta accerta</kwd>
<kwd>individualize</kwd>
<kwd>PAS management</kwd>
<kwd>hysterectomie</kwd>
<kwd>topographic classification</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/><equation-count count="0"/><ref-count count="16"/><page-count count="0"/><word-count count="0"/></counts>
</article-meta>
</front>
<body>
<p>Placenta accreta spectrum (PAS) is an entity with a wide range of clinical presentations. From cases with &#x201C;mild&#x201D; lesions requiring moderate surgical effort and are associated with few complications (<xref ref-type="bibr" rid="B1">1</xref>), to severe ones with a challenging management and life-threatening risk (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>Individualizing the management of PAS patients is essential, especially when a significant percentage of women undergoing PAS surgery ultimately do not have this diagnosis or present superficial or focal lesions (<xref ref-type="bibr" rid="B3">3</xref>). In addition, let&#x0027;s not forget that some women wish to preserve their fertility (<xref ref-type="bibr" rid="B4">4</xref>) or that vascular interventions or the hysterectomy itself can cause additional morbidity (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>However, customizing the management of PAS seems complicated. Choosing the ideal management for each patient is a task for personal and institutional reasons.</p>
<p>Although multiple treatments have been described (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>), frequently, each PAS team adopts one strategy for all cases and specializes in its performance. Applying this type of intervention becomes the norm for all patients with PAS presenting at a specific hospital. Additionally, historic international consensus focuses on hysterectomy as the standard treatment, mentioning other management alternatives as secondary options &#x201C;only&#x201D; for exceptional cases (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B8">8</xref>). There is practically no doubt that supervised training modify this previous concept.</p>
<p>On the other hand, the preoperative classification based on the severity of the placenta invasion needs a subsequent histological analysis (<xref ref-type="bibr" rid="B9">9</xref>). Therefore, pathologic tissue analysis does not help make decisions on the table, and histological study is subject to multiple biases.</p>
<p>The placenta invasion topography is closely related to surgical complexity and maternal morbidity (<xref ref-type="bibr" rid="B10">10</xref>). Placenta invasion below the peritoneal reflection implies more significant risks due to reduced space, extrauterine arterial pedicles&#x2019; multiplicity, and requirement for adequate vascular control strategies (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>It is essential to validate an applicable classification before non-reversible maneuvres (that is, before incising the uterus and causing bleeding) that also suggests a specific type of treatment according to the characteristics of each case. The accurate dissection of coalescence pelvic fascia&#x0027;s spaces allows using avascular spaces with minimal tissue manipulation to have a precise diagnosis and avoid possible complications, this is the principle of intraoperative PAS staging. Additionally, the surgical staging allows getting objective PAS&#x00A0;information that could be missing after prenatal ultrasound (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>Although it is possible to make a diagnostic approach based on the results of prenatal images (ultrasonography and MRI), it is during the laparotomy for the cesarean section when the surgeon can use safe and straightforward dissection techniques to establish the affected area of the uterus, and consequently, the risk of massive bleeding or organ injury.</p>
<p>Topographic classification seeks to define which uterine wall is affected (anterior, lateral, or posterior), the presence of lesions above the level of peritoneal reflection (high lesions) or below that level (low or &#x201C;subperitoneal&#x201D; lesions), and the nature of the lesion (characterized by neovascularization or with the presence of fibrosis between the uterus and neighboring organs). The main objective of the intraoperative topographic classification of PAS (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>) is to use the most suitable PAS treatment according to objective surgical findings.</p>
<p>Each of the possible affected uterine areas is related to well-defined anatomical arterial pedicles and neighboring structures (urinary and vascular) that determine the surgical difficulty and the recommended dissection and management strategies (<xref ref-type="bibr" rid="B16">16</xref>) (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>).</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Intraoperative staging makes it possible to determine which uterine wall is affected and the relationship of the lesion to the vesicouterine peritoneal fold (above or below that level), as well as the predominance of neovascularization or the presence of vesicouterine fibrosis.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frph-04-1096175-g001.tif"/>
</fig>
<p>The topographic classification establishes a &#x201C;conceptual 3D map&#x201D; and different management options for each case. For example, what the PAS teams call &#x201C;A, B, and C plans,&#x201D; necessary when facing the wide variety of PAS clinical presentations, does not necessarily require the same management route in all cases.</p>
<p>Some publications described the advantages of topographic classification in retrospective studies (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>). Hopefully, the comparison between individualized arterial pedicles control and the mandatory use of interventional radiology in all the cases could be promissory in large prospective multicentric studies. Likewise, the topographic classification, followed by a protocolized and individualized management, can enhance the postoperative histological analysis.</p>
<p>In each topography, some arterial pedicles are identified that provide most of the irrigation to the PAS area and that determine the recommended vascular procedures and the type of treatment necessary (One Step Conservative Surgery [OSCS], Total hysterectomy or Modified SubTotal Hysterectomy [MSTH]).</p>
<p>Type 0 PAS: uterine &#x201C;window&#x201D; or dehiscense. Type 1 PAS: uterine segment upper part involvement. Type 2 PAS: parametrial involvement (2U: upper parametrial involvement, 2&#x2005;L: lower parametrial involvement). Type 3 PAS: cervix or uterine segment lower part involvement (below the peritoneal reflection). Type 4 PAS: type 3 PAS plus vesicouterine fibrosis. Type 5 PAS: uterine posterior wall involvement (5U: involvement of the upper part of that wall. 5&#x2005;L: Lesions below the level of the peritoneal reflection).</p>
</body>
<back>
<sec id="s1"><title>Author contributions</title>
<p>JP, AN, RA and NB contributed to the design, planning, data analysis and manuscript writing. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s2" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s3" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kingdom</surname><given-names>JC</given-names></name><name><surname>Hobson</surname><given-names>SR</given-names></name><name><surname>Murji</surname><given-names>A</given-names></name><name><surname>Allen</surname><given-names>L</given-names></name><name><surname>Windrim</surname><given-names>RC</given-names></name><name><surname>Lockhart</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020</article-title>. <source>Am J Obstet Gynecol</source>. (<year>2020</year>) <volume>223</volume>(<issue>3</issue>):<fpage>322</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2020.01.044</pub-id>.<pub-id pub-id-type="pmid">32007492</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nieto-Calvache</surname><given-names>AJ</given-names></name><name><surname>Palacios-Jaraquemada</surname><given-names>JM</given-names></name><name><surname>Osanan</surname><given-names>G</given-names></name><name><surname>Cortes-Charry</surname><given-names>R</given-names></name><name><surname>Aryananda</surname><given-names>RA</given-names></name><name><surname>Bangal</surname><given-names>VB</given-names></name><etal/></person-group> <article-title>Lack of experience is a main cause of maternal death in placenta accreta spectrum patients</article-title>. <source>Acta Obstet Gynecol Scand</source>. (<year>2021</year>) <volume>100</volume>(<issue>8</issue>):<fpage>1445</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1111/aogs.14163</pub-id>.<pub-id pub-id-type="pmid">33896009</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>AM</given-names></name><name><surname>Elbarmelgy</surname><given-names>RA</given-names></name><name><surname>Elbarmelgy</surname><given-names>RM</given-names></name><name><surname>Thabet</surname><given-names>MM</given-names></name><name><surname>Jauniaux</surname><given-names>E</given-names></name></person-group>. <article-title>Prospective evaluation of the impact of post-cesarean section uterine scarification in the perinatal diagnosis of placenta accreta spectrum [published online ahead of print, 2021 Jul 5]</article-title>. <source>Ultrasound Obstet Gynecol</source>. (<year>2021</year>) 59(4):474&#x2013;82. <pub-id pub-id-type="doi">10.1002/uog.23732</pub-id>.</citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Einerson</surname><given-names>BD</given-names></name><name><surname>Watt</surname><given-names>MH</given-names></name><name><surname>Sartori</surname><given-names>B</given-names></name><name><surname>Silver</surname><given-names>R</given-names></name><name><surname>Rothwell</surname><given-names>E</given-names></name></person-group>. <article-title>Lived experiences of patients with placenta accreta spectrum in Utah: a qualitative study of semi-structured interviews</article-title>. <source>BMJ Open</source>. (<year>2021</year>) <volume>11</volume>(<issue>11</issue>):<fpage>e052766</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2021-052766</pub-id><pub-id pub-id-type="pmid">34732490</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whittington</surname><given-names>JR</given-names></name><name><surname>Pagan</surname><given-names>ME</given-names></name><name><surname>Nevil</surname><given-names>BD</given-names></name><name><surname>Kalkwarf</surname><given-names>KJ</given-names></name><name><surname>Sharawi N</surname><given-names>el</given-names></name><name><surname>Hughes</surname><given-names>DS</given-names></name><etal/></person-group> <article-title>Risk of vascular complications in prophylactic compared to emergent resuscitative endovascular balloon occlusion of the aorta (REBOA) in the management of placenta accreta spectrum [published online ahead of print, 2020 Aug 11]</article-title>. <source>J Matern Fetal Neonatal Med</source>. (<year>2020</year>) 35(16):<fpage>1</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1080/14767058.2020.1802717</pub-id>.<pub-id pub-id-type="pmid">29804488</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>L</given-names></name><name><surname>Jauniaux</surname><given-names>E</given-names></name><name><surname>Hobson</surname><given-names>S</given-names></name><name><surname>Papillon-Smith</surname><given-names>J</given-names></name><name><surname>Belfort</surname><given-names>MA</given-names></name></person-group>. <article-title>FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management</article-title>. <source>Int J Gynaecol Obstet</source>. (<year>2018</year>) <volume>140</volume>(<issue>3</issue>):<fpage>281</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1002/ijgo.12409</pub-id>.<pub-id pub-id-type="pmid">29405317</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sentilhes</surname><given-names>L</given-names></name><name><surname>Kayem</surname><given-names>G</given-names></name><name><surname>Chandraharan</surname><given-names>E</given-names></name><name><surname>Palacios-Jaraquemada</surname><given-names>J</given-names></name><name><surname>Jauniaux</surname><given-names>E</given-names></name></person-group>. <article-title>FIGO placenta accreta diagnosis and management expert consensus panel. FIGO&#x00A0;consensus guidelines on placenta accreta spectrum disorders: conservative&#x00A0;management</article-title>. <source>Int J Gynaecol Obstet</source>. (<year>2018</year>) <volume>140</volume>(<issue>3</issue>):<fpage>291</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/ijgo.12410</pub-id>.<pub-id pub-id-type="pmid">29405320</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>SL</given-names></name><name><surname>Alemdar</surname><given-names>B</given-names></name><name><surname>van Beekhuizen</surname><given-names>HJ</given-names></name><name><surname>Bertholdt</surname><given-names>C</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><name><surname>Calda</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta</article-title>. <source>Am J Obstet Gynecol</source>. (<year>2019</year>) <volume>220</volume>(<issue>6</issue>):<fpage>511</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2019.02.054</pub-id>.<pub-id pub-id-type="pmid">30849356</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jauniaux</surname><given-names>E</given-names></name><name><surname>Ayres-de-Campos</surname><given-names>D</given-names></name><name><surname>Langhoff-Roos</surname><given-names>J</given-names></name><name><surname>Fox</surname><given-names>KA</given-names></name><name><surname>Collins</surname><given-names>S</given-names></name></person-group>. <article-title>FIGO placenta accreta diagnosis and management expert consensus panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders</article-title>. <source>Int J Gynaecol Obstet</source>. (<year>2019</year>) <volume>146</volume>(<issue>1</issue>):<fpage>20</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/ijgo.12761</pub-id>.<pub-id pub-id-type="pmid">31173360</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cali</surname><given-names>G</given-names></name><name><surname>Forlani</surname><given-names>F</given-names></name><name><surname>Lees</surname><given-names>C</given-names></name><name><surname>Timor-Tritsch</surname><given-names>I</given-names></name><name><surname>Palacios-Jaraquemada</surname><given-names>J</given-names></name><name><surname>Dall&#x2019;Asta</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Prenatal ultrasound staging system for placenta accreta spectrum disorders</article-title>. <source>Ultrasound Obstet Gynecol</source>. (<year>2019</year>) <volume>53</volume>(<issue>6</issue>):<fpage>752</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1002/uog.20246</pub-id>.<pub-id pub-id-type="pmid">30834661</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palacios-Jaraquemada</surname><given-names>JM</given-names></name><name><surname>D&#x2019;Antonio</surname><given-names>F</given-names></name><name><surname>Buca</surname><given-names>D</given-names></name><name><surname>Fiorillo</surname><given-names>A</given-names></name><name><surname>Larraza</surname><given-names>P</given-names></name></person-group>. <article-title>Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome</article-title>. <source>J Matern Fetal Neonatal Med</source>. (<year>2020</year>) <volume>33</volume>(<issue>19</issue>):<fpage>3377</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1080/14767058.2019.1570494</pub-id>.<pub-id pub-id-type="pmid">30700221</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palacios-Jaraquemada</surname><given-names>JM</given-names></name><name><surname>D&#x2019;Antonio</surname><given-names>F</given-names></name><name><surname>Buca</surname><given-names>D</given-names></name><name><surname>Fiorillo</surname><given-names>A</given-names></name><name><surname>Larraza</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Comparing three-dimensional models of placenta accreta spectrum with surgical findings [published online ahead of print, 2021 May 17]</article-title>. <source>Int J Gynaecol Obstet</source>. (<year>2021</year>) 33(19):3377&#x2013;84. <pub-id pub-id-type="doi">10.1002/ijgo.13743</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silveira</surname><given-names>C</given-names></name><name><surname>Kirby</surname><given-names>A</given-names></name><name><surname>Melov</surname><given-names>SJ</given-names></name><name><surname>Nayyar</surname><given-names>R</given-names></name></person-group>. <article-title>Placenta accreta spectrum: we can do better [published online ahead of print, 2022 Jan 4]</article-title>. <source>Aust N Z J Obstet Gynaecol</source>. (<year>2022</year>) 62(3):376&#x2013;82. <pub-id pub-id-type="doi">10.1111/ajo.13471</pub-id><pub-id pub-id-type="pmid">34984671</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palacios-Jaraquemada</surname><given-names>JM</given-names></name><name><surname>Fiorillo</surname><given-names>A</given-names></name><name><surname>Hamer</surname><given-names>J</given-names></name><name><surname>Mart&#x00ED;nez</surname><given-names>M</given-names></name><name><surname>Bruno</surname><given-names>C</given-names></name></person-group>. <article-title>Placenta accreta spectrum: a hysterectomy can be prevented in almost 80&#x0025; of cases using a resective-reconstructive technique</article-title>. <source>J Matern Fetal Neonatal Med</source>. (<year>2022</year>) <volume>35</volume>(<issue>2</issue>):<fpage>275</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1080/14767058.2020.1716715</pub-id>.<pub-id pub-id-type="pmid">31984808</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nieto-Calvache</surname><given-names>AJ</given-names></name><name><surname>Palacios-Jaraquemada</surname><given-names>JM</given-names></name><name><surname>Aryananda</surname><given-names>RA</given-names></name><name><surname>Rodriguez</surname><given-names>F</given-names></name><name><surname>Ordo&#x00F1;ez</surname><given-names>CA</given-names></name><name><surname>Messa Bryon</surname><given-names>A</given-names></name><etal/></person-group> <article-title>How to identify patients who require aortic vascular control in placenta accreta spectrum disorders? [published online ahead of print, 2021 Oct 2]</article-title>. <source>Am J Obstet Gynecol MFM</source>. (<year>2021</year>) <volume>4</volume>(<issue>1</issue>):<fpage>100498</fpage>. <pub-id pub-id-type="doi">10.1016/j.ajogmf.2021.100498</pub-id>.<pub-id pub-id-type="pmid">34610485</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palacios Jaraquemada</surname><given-names>JM</given-names></name><name><surname>Garc&#x00ED;a M&#x00F3;naco</surname><given-names>R</given-names></name><name><surname>Barbosa</surname><given-names>NE</given-names></name><name><surname>Ferle</surname><given-names>L</given-names></name><name><surname>Iriarte</surname><given-names>H</given-names></name><name><surname>Conesa</surname><given-names>HA</given-names></name></person-group>. <article-title>Lower uterine blood supply: extrauterine anastomotic system and its application in surgical devascularization techniques</article-title>. <source>Acta Obstet Gynecol Scand</source>. (<year>2007</year>) <volume>86</volume>(<issue>2</issue>):<fpage>228</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1080/00016340601089875</pub-id>.<pub-id pub-id-type="pmid">17364288</pub-id></citation></ref></ref-list>
</back>
</article>